Advances in Medicinal Chemistry (4)

Author: Peng Suxun
Publisher:
Publish Date: 2005-05-01
Features: This book is the fourth volume in the series "Advances in Medicinal Chemistry," which invites experts in medicinal chemistry and related disciplines from various research fields to contribute forward-looking and guiding articles. It aims to reflect the latest advances in upstream research in drug development, providing insights, clarifying methods, and offering ideas for drug researchers in China. The book includes 15 articles, among which 3 discuss the design, strategies, and approaches in drug research, including privileged structures and their applications in drug discovery, recent progress in RNA interference and drug research, and new ideas and methods in drug research. Three articles focus on cardiovascular and cerebrovascular drugs, covering research progress in drugs for chronic heart failure, endothelin receptor antagonists for heart failure, and ion channels and cerebral ischemia. Three articles describe antitumor drugs, including research progress on topoisomerase I inhibitors, second-generation taxane analogs as anticancer drugs, and indole alkaloids as antitumor agents. Two articles elaborate on natural drugs, featuring research progress on Eudistomin alkaloids with significant bioactivity and pentacyclic triterpenoids as natural products. Additionally, four other articles cover research progress in non-steroidal anti-inflammatory drugs, drugs for peptic ulcer treatment, glycosidase inhibitors, and 5-HT3 receptor and its drug research. This book is suitable for drug researchers and can also serve as a reference for senior undergraduate and graduate students in related fields.
Introduction: This book is the fourth volume in the series "Advances in Medicinal Chemistry," which invites experts in medicinal chemistry and related disciplines to contribute forward-looking and guiding articles. It aims to reflect the latest advances in upstream research in drug development, providing insights, clarifying methods, and offering ideas for drug researchers in China. The book includes 15 articles, among which 3 discuss the design, strategies, and approaches in drug research, including privileged structures and their applications in drug discovery, recent progress in RNA interference and drug research, and new ideas and methods in drug research. Three articles focus on cardiovascular and cerebrovascular drugs, covering research progress in drugs for chronic heart failure, endothelin receptor antagonists for heart failure, and ion channels and cerebral ischemia. Three articles describe antitumor drugs, including research progress on topoisomerase I inhibitors, second-generation taxane analogs as anticancer drugs, and indole alkaloids as antitumor agents. Two articles elaborate on natural drugs, featuring research progress on Eudistomin alkaloids with significant bioactivity and pentacyclic triterpenoids as natural products. Additionally, four other articles cover research progress in non-steroidal anti-inflammatory drugs, drugs for peptic ulcer treatment, glycosidase inhibitors, and 5-HT3 receptor and its drug research. This book is suitable for drug researchers and can also serve as a reference for senior undergraduate and graduate students in related fields.
Table of Contents